{"id":1963071,"date":"2023-07-03T07:51:02","date_gmt":"2023-07-03T11:51:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-shares-drop-as-lung-cancer-trial-update-lags-expectations\/"},"modified":"2023-07-03T07:53:41","modified_gmt":"2023-07-03T11:53:41","slug":"astrazeneca-shares-drop-as-lung-cancer-trial-update-lags-expectations","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-shares-drop-as-lung-cancer-trial-update-lags-expectations\/","title":{"rendered":"AstraZeneca shares fall as lung cancer trial update disappoints."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">18<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fastrazeneca-shares-drop-as-lung-cancer-trial-update-lags-expectations%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=1963071&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><div class=\"entry-content\">\n<h2>AstraZeneca&#8217;s Precision Drug Shows Promise in Lung Cancer Trial<\/h2>\n<blockquote>\n<p>By Maggie Fick and Ludwig Burger<\/p>\n<\/blockquote>\n<p>(Reuters) \u2013 AstraZeneca announced on Monday that their experimental precision drug, datopotamab deruxtecan, has demonstrated a significant slowdown in the progression of lung cancer in a late-stage trial. However, despite the positive results, the company&#8217;s shares fell by as much as 6% as analysts expressed concerns about the potential benefits.<\/p>\n<div id=\"div-gpt-ad-1663871513696-art-1\" style=\"min-width: 320px; min-height: 50px;  text-align: center;\">  \t<script>  \t\tgoogletag.cmd.push(function() { googletag.display('div-gpt-ad-1663871513696-art-1'); });  \t<\/script>  <\/div>\n<div class=\"ad-slot__ad-label\">Advertisement<\/div>\n<\/p>\n<p>The precision drug, developed in collaboration with Japan&#8217;s Daiichi Sankyo, has shown to prolong progression-free survival compared to standard chemotherapy in patients with non<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-slows-approval-of-affordable-cancer-drug-in-the-name-of-racial-equity\/\" title=\"FDA Slows Approval Of Affordable Cancer Drug In The Name Of Racial \u2018Equity\u2019\">-small cell lung cancer<\/a> that has relapsed after previous treatment attempts, according to AstraZeneca.<\/p>\n<p>This drug belongs to a <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-shares-drop-as-lung-cancer-trial-update-lags-expectations\/\" title=\"AstraZeneca shares fall as lung cancer trial update disappoints.\">promising class called antibody drug conjugates<\/a> (ADC), which combines tumor-seeking monoclonal antibodies with cell-killing chemotherapy.<\/p>\n<p>AstraZeneca also noted that some participants in the trial had died from interstitial lung disease, but assured that the drug&#8217;s safety profile aligns with observations from previous clinical trials.<\/p>\n<p>Further details of the trial will be presented at an upcoming medical conference.<\/p>\n<p>Despite the setback in share prices, AstraZeneca remains optimistic about the potential of datopotamab deruxtecan. The drug&#8217;s cell-killing molecules target a protein called TROP2, which is associated with the majority of lung cancers. Other pharmaceutical companies, such as Gilead, Merck &#038; Co, and Kelun-Biotech, are also exploring similar drug candidates in this class.<\/p>\n<p>AstraZeneca acquired the collaboration rights to this experimental drug in a 2020 deal worth up to $6 billion with Daiichi, including up to $4 billion contingent on sales. The partnership has already seen success with the ADC drug Enhertu against breast cancer and other tumors.<\/p>\n<p>The trial for datopotamab deruxtecan will continue as planned to assess its impact on overall patient survival, a crucial measure of efficacy.<\/p>\n<p>Barclays analysts acknowledged the success of the trial but cautioned that more data is needed before determining if the drug could become a preferred treatment option after diagnosis. They advised investors to view any negative reaction as a potential buying opportunity.<\/p>\n<\/p>\n<p> (Reporting by Maggie Fick in London, Ludwig Burger in Frankfurt and Sinchita Mitra in Bengaluru; Additional reporting by Lucy Raitano in London; Editing by Krishna Chandra Eluri and Susan Fenton)<\/p>\n<p><a href=\"https:\/\/www.oann.com\/uncategorized\/astrazeneca-shares-drop-as\/attachment\/file-photo-test-tubes-are-seen-in-front-of-a-2\/\"><\/a><\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Insights on the Economy Under Biden<\/h3>\n<p>Heading into 2024, many voters aren&#8217;t feeling positive about the economy under Biden. One America&#8217;s Monica Paige is joined by a <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/cuomo-to-partially-reopen-indoor-dining-in-nyc-for-valentines-day-if-positivity-rates-hold\/\" title=\"Cuomo To Partially Reopen Indoor Dining In NYC For Valentine\u2019s Day, \u2018If Positivity Rates Hold\u2019\">small business owner<\/a> for his insight on the state of the economy.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Efforts to Remove Inappropriate Books from Public Library<\/h3>\n<p>One America&#8217;s Bridget Bosco speaks with a Front Royal, VA mom and community organizer, Colleen DeLaFleur, about parents&#8217; efforts to get pornographic and objectionable books out of the public library.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Actor Jim Caviezel Discusses &#8220;Sound of Freedom&#8221;<\/h3>\n<p>One America&#8217;s Bridget Bosco speaks with actor Jim Caviezel, who plays Tim Ballard in &#8220;Sound of Freedom.&#8221;<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>President Trump Celebrates Independence Day in Pickens, South Carolina<\/h3>\n<p>President Trump is heading to Pickens, South Carolina on Saturday to celebrate Independence Day.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Apple Faces Production Challenges for Vision Pro AR Headset<\/h3>\n<p>(Reuters) &#8211; Apple has been forced to make major cuts to production forecasts for its Vision Pro augmented-reality headset due to design complexity&#8230;<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>EU and Japan Strengthen Cooperation on Semiconductors<\/h3>\n<p>By Sam Nussey TOKYO (Reuters) &#8211; The European Union (EU) will deepen cooperation with Japan on semiconductors, industry chief Thierry Breton said on&#8230;<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Japan Considers Softer Rules for AI Use<\/h3>\n<p>By Sam Nussey and Tim Kelly TOKYO (Reuters) \u2013 Japan is leaning toward <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/panasonic-needs-four-more-ev-battery-plants-executive-says\/\" title=\"Panasonic executive insists on four additional EV battery plants for Panasonic.\">softer rules governing<\/a> the use of artificial intelligence (AI)&#8230;<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<h3>Elon Musk Limits Twitter Users&#8217; Post Access<\/h3>\n<p>By Jody Godoy (Reuters) &#8211; Elon Musk&#8217;s move to temporarily cap how many posts Twitter users can read on the social media&#8230;<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>developed by AstraZeneca, showed promising results in a recent lung cancer trial. However, the company&#8217;s shares dropped by 6% due to analysts&#8217; concerns about the drug&#8217;s effectiveness.<\/p>\n","protected":false},"author":66,"featured_media":1963072,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[542],"tags":[],"class_list":["post-1963071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oann"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/1963071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/66"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=1963071"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/1963071\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/1963072"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=1963071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=1963071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=1963071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}